Debdutta Bandyopadhyay

1PUBLICATIONS
2CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 14, 2020
ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer.

Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani

Pageof 1